RDGL · Vivos Inc
$0.06
+0.00 (+2.06%)
At close · Jul 30
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's financial history since inception, the Company's independent registered public accounting firm has expressed substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$29.33M
Shares
493.89M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$68.38K
+1268.9%
FY2025
Net Income
-$3.07M
-5.3%
FY2025
Gross Margin
-87.39%
-27.6pp
FY2025
Operating Margin
-4628.68%
+47511.1pp
FY2025
Diluted EPS
-$0.01
0%
FY2025
Operating Cash Flow
-$2.06M
-22.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $77.7K | $68.38K | $4995 | $19.5K | $36.5K | $14.89K | $7000 | $9500 | — | $4054 | — | — | — | — | — | — | — | |
| $82.47K | $99.03K | $74.94K | $49.58K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $136.39K | $128.13K | $30.98K | $25.54K | $28.78K | $12K | $5608 | $6028 | — | — | $0 | $474 | $1104 | $105.33K | $72.82K | $64.04K | $70.13K | |
| -$58.69K | -$59.76K | -$2984 | -$6036 | $7720 | $2887 | $1392 | $3472 | — | — | — | — | — | — | — | — | — | |
| — | -87.39% | -59.74% | -30.95% | 21.15% | 19.39% | 19.89% | 36.55% | — | — | — | — | — | — | — | — | — | |
| $270.87K | $352.23K | $324.63K | $732.7K | $343.8K | $286.85K | $84.67K | $67.58K | $104.21K | $203.04K | $328.03K | $149.65K | $44.27K | — | — | — | — | |
| — | — | — | — | — | — | — | — | $11.5K | $111.66K | $284.14K | $0 | $1300 | $9912 | $18.31K | $58.88K | $29.07K | |
| $303.04K | $296.56K | $241.82K | $165.77K | $151.11K | $112.04K | $109.03K | $74.33K | $98.64K | $109.46K | $432.47K | $408.31K | $401.3K | $1.22M | $1.12M | $564.66K | $544.5K | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $1339 | $5832 | $8889 | $11.16K | $6668 | $5693 | |
| — | — | — | — | — | — | — | — | — | $1473 | $2947 | $5672 | $11.99K | $208.63K | $483.2K | $546.39K | $545.19K | |
| $2.79M | $3.11M | $2.6M | $2.79M | $2.53M | $2.5M | $673.91K | $1.33M | $2.49M | $2.62M | $4.44M | $2.07M | $1.98M | $3.72M | $6.12M | $2.96M | $4.09M | |
| -$2.85M | -$3.17M | -$2.6M | -$2.79M | -$2.52M | -$2.5M | -$672.52K | -$1.33M | -$2.49M | -$2.62M | -$4.44M | -$2.04M | -$1.96M | -$3.58M | -$5.87M | -$2.56M | -$3.73M | |
| — | -4628.68% | -52139.82% | -14323.83% | -6898.13% | -16805.25% | -9607.44% | -13999.78% | — | -64551.41% | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | -$2.62M | -$4.43M | -$2.04M | -$1.94M | -$3.37M | -$5.39M | -$2.02M | -$3.18M | |
| — | — | — | — | — | $25.38K | $287.47K | $261.37K | $5.65M | $3.9M | $6.26M | $3.2M | $2.46M | $1.6M | $1.1M | $408.47K | $860.25K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $599 | |
| -$569.16K | $99.03K | -$306.06K | -$101.61K | $47.59K | -$25.97K | -$284.47K | -$280.12K | -$5.21M | -$3.8M | -$5.42M | $8.27M | -$16.15M | $108.81K | -$2.72M | -$187.75K | -$329.69K | |
| -$3.42M | -$3.07M | -$2.91M | -$2.89M | -$2.47M | -$2.53M | -$956.99K | -$1.61M | -$7.7M | -$6.42M | -$9.85M | $6.23M | -$18.11M | -$3.47M | -$8.59M | -$2.75M | -$4.06M | |
| — | — | — | — | — | $0 | $0 | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$3.42M | -$3.07M | -$2.91M | -$2.89M | -$2.47M | -$2.53M | -$956.99K | -$1.61M | -$7.7M | -$6.42M | -$9.85M | $6.23M | -$18.11M | -$3.47M | -$8.59M | -$2.75M | -$4.06M | |
| — | -4483.86% | -58267.23% | -14844.89% | -6767.75% | -16979.69% | -13671.31% | -16948.39% | — | -158330.71% | — | — | — | — | — | — | — | |
| USD/shares | — | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | — | — | — | — | — | -$0.06 | -$0.03 | -$0.11 | -$0.04 | -$0.07 |
| USD/shares | — | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 452.72M | 409.67M | 368.81M | 351.43M | 325.85M | 222.8M | 175.2M | 55.5M | 48.39M | 21.5M | 18.51M | 319.27M | 100.69M | 75.67M | 69.35M | 56.17M |
| shares | — | 452.72M | 409.67M | 368.81M | 351.43M | — | — | — | 444.01M | 48.39M | 21.5M | 18.51M | 13.87B | 106.74M | 62.05M | 17.13M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.27×
EV/EBIT
—
Peer median 18.29×
P/E (TTM)
—
Peer median 7.61×
Peer medians compare against the 71 similar-size Medical Devices companies (of 145 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| IsoPet | $143,025 | — |
| Services Treatments | $88,875 | $29,995 |
| Certification | $37,483 | — |
| Polymer | $1,056 | — |
| Freight | $1,050 | — |
| Discount Certifications | -$9,995 | — |
| Discount Services | -$71,815 | -$2,000 |
| Discount IsoPet | -$121,300 | — |